Radiation, conception and pregnancy

Nuclear Medicine Communications

Volumn 20, Issue 11, 1999, Pages 979-982

  Mountford, P J ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOSIMETRY; EDITORIAL; NUCLEAR MEDICINE; PREGNANCY; RADIATION EXPOSURE; RISK ASSESSMENT;

FEMALE; FERTILIZATION; HUMANS; MALE; PREGNANCY; RADIOMETRY; RISK ASSESSMENT;

EID: 0032739466     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199911000-00001     Document Type: Article

References (22)

1. Sharp C, Shrimpton JA, Bury RF. Diagnostic medical exposures: Advice on exposure to ionising radiation during pregnancy. Chilton, Oxon: National Radiological Protection Board, 1998.
2. National Radiological Protection Board. Board statement on diagnostic medical exposures to ionising radiation during pregnancy. Documents of the NRPB, Vol. 4, No. 4. London: HMSO, 1993: 1-14.
3. Administration of Radioactive Substances Advisory Committee. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. London: Department of Health, 1998.
4. Stabin MG. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538-546.
5. Palmer AM, Preece AW. Placental transfer of technetium labelled radiopharmaceuticals in the guinea pig. J Nucl Med 1993; 34: 159P.
6. Preece AW, Palmer AM, Saunders M. Fetal distribution of pertechnetate and “Tcm-MAA-relevance to fetal radiation dose from lung scans in pregnancy. Br J Radiol 1998; 71 (suppl.): 17.
7. Palmer AM. Comparison of placental transfer of radioiodine and technetium in guinea pigs and mice. Eur J Nucl Med 1997; 24: 964.
8. Palmer AM. Fetal radiation dose from 67Ga-citrate admin-istered during pregnancy. Nucl Med Commun 1997; 18: 333.
9. Palmer AM, Saunders M, Preece AW. Placental transfer of “Tcm-MAG3-radiation dose to the fetus following renal imaging in pregnancy. Br J Radiol 1999; 72 (suppl.): 78.
10. Russell JR, Stabin MG, Sparks RB. Placental transfer of radiopharmaceuticals and dosimetry in pregnancy. Health Phys 1997; 73: 747-755.
11. Russell JR, Stabin MG, Sparks RB, Watson E. Radiation absorbed dose to the embryo/fetus from radiopharmaceut-icals. Health Phys 1997; 73: 756-769.
12. Palmer AM, Saunders M, Preece AW. The use of a human in vitro model to screen the placental transfer of radiophar-maceuticals. Br J Radiol 1999; 72 (suppl.): 78.
13. Casara D, Rubello D, Saladini G et al. Pregnancy after high therapeutic doses of iodine-131 in differentiated cancer: Potential risks and recommendations. Eur J Nucl Med 1993; 20: 192-194.
14. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid cancer. J Nucl Med 1995; 36: 21-27.
15. Schlumberger M, De Vathaire F, Ceccarelli C et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996; 37: 606-612.
16. Safa AM, Schumaker OP, Rodriguez-Antunez A. Longterm follow-up in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. NEJM 1975; 292: 167-171.
17. Sarker SD, Beierwaltes WH, Gill SP, Cowley BJ. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med 1976; 17: 460-464.
18. Doll R, Evans HJ, Darby SC. Paternal exposure not to blame. Nature 1994; 367: 678-680.
19. Kilmer BF. Prenatal irradiation: A major concern for the developing brain. Int J Radiat Biol 1998; 73: 423-434.
20. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol 1997; 70: 130-139.
21. Staffer SS, Hamburger JI. Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med 1976; 17: 146-149.
22. Berg GEB, Nystrom EH, Jacobsson L et al. Radioiodine treatment of hyperthyroidism in a pregnant woman. J Nucl Med 1998; 39: 357-361.